XML 72 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Income (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Product revenues $ 662,082 $ 554,979 $ 369,588
Cost of sales 487,320 413,052 274,621
Gross margin 174,762 141,927 94,967
Operating costs and expenses:      
Research and development expenses 52,197 43,189 30,665
Reimbursed research and development expenses (2,324) (2,239) (932)
Net research and development expenses 49,873 40,950 29,733
Acquisition transaction expenses 2,414   5,316
Selling, general and administrative expenses 72,895 64,919 42,110
Total operating costs and expenses 125,182 105,869 77,159
Operating income 49,580 36,058 17,808
Interest (expense) (3,543) (4,136) (3,511)
Debt retirement expense     (1,160)
Revaluation of derivatives 1,006 (2,292) (6,118)
Foreign currency (loss) gain (2,228) 2,201 9,207
Gain (loss) from equity investment 436 (82) (243)
Other income (loss) 979 923 (114)
Earnings before income tax 46,230 32,672 15,869
Income tax expense 11,097 8,351 4,666
Net income 35,133 24,321 11,203
Income attributable to non-controlling interest (1,313) (6,449) (1,545)
Net income attributable to Gentherm, Inc. 33,820 17,872 9,658
Convertible preferred stock dividends (1,622) (6,711) (8,228)
Net income attributable to common shareholders $ 32,198 $ 11,161 $ 1,430
Basic earnings per share $ 0.96 $ 0.39 $ 0.06
Diluted earnings per share $ 0.94 $ 0.39 $ 0.06
Weighted average number of shares—basic 33,652,646 28,352,864 22,605,518
Weighted average number of shares—diluted 34,123,641 28,862,463 23,454,622